Condensed Consolidated Statements Of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Net revenue	$ 18,839,000	$ 9,802,000
Cost of revenue	11,666,000	7,036,000
Gross profit	7,173,000	2,766,000
Operating expenses:
Research and development	2,164,000	2,471,000
Sales and marketing	3,916,000	4,603,000
General and administrative	5,070,000	4,780,000
Total operating expenses	11,150,000	11,854,000
Loss from operations	(3,977,000)	(9,088,000)
Other (income) expenses, net:
Change in fair value of contingent shares liability		(196,000)
Interest expense	2,871,000	2,826,000
Other income, net	(143,000)	(212,000)
Total other expenses, net	2,728,000	2,418,000
Loss before income tax expense	(6,705,000)	(11,506,000)
Income tax expense	296,000	0
Net loss	(7,001,000)	(11,506,000)
Other comprehensive loss:
Unrealized (loss) gain resulting from change in fair value of marketable securities	(2,000)	12,000
Total comprehensive loss	$ (7,003,000)	$ (11,494,000)
Loss per common share
Basic	$ (0.11)	$ (0.19)
Diluted	$ (0.11)	$ (0.19)
Weighted-average common shares outstanding
Basic	61,657,718	59,374,019
Diluted	61,657,718	59,374,019